ArticleBiomedicines2022

Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.

Simona Biscarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.